Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Aug 4;89(3):552-6.
doi: 10.1038/sj.bjc.6601127.

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer

J Edwards  1 , N S Krishna, K M Grigor, J M S Bartlett
Affiliations

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer

J Edwards et al. Br J Cancer. .

Abstract

This study examined androgen receptor (AR) gene amplification and protein expression in 102 matched paired hormone sensitive and resistant tumours from 51 patients. AR gene amplification and X chromosome copy number were assessed by fluorescent in situ hybridisation, and protein expression was assessed by immunohistochemistry. All tumours were stained for PSA protein expression. Significantly more tumours exhibited AR amplification following the development of hormone resistance (20%, 10 out of 49) compared to matched hormone-sensitive tumours from the same patient (2%, one out of 48) (P=0.0085). The level of AR expression was significantly higher in hormone-resistant tumours compared to matched hormone-sensitive tumours from the same patient (130, interquartile range, 55-167 vs 94.5 interquartile range, 55-120, P=0.019). AR expression levels in hormone-resistant tumours with and without AR amplification were not significantly different. However, an increase in AR expression was seen with the development of AR amplification in paired tumours. The rate of AR gene amplification and/or an increase in AR protein expression during androgen resistant is too low to wholly explain the development of androgen resistance. Alternative mechanisms for modulating the function of the AR, or other signalling pathways, must be considered as key factors in the development of hormone-resistant prostate.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A prostate cancer tumour with AR gene amplification is shown. AR amplification in prostate cancer nuclei (stained with DAPI, blue) showing increased copies of both AR (red) and chromosome X (green). Magnification × 1000.
Figure 2
Figure 2
A prostate cancer tumour that expresses AR protein is shown. AR protein expression is coloured brown and is present in the tumour cell nuclei. Magnification × 400.
Figure 3
Figure 3
(A) The AR protein mean histoscore for matched hormone-sensitive and hormone-resistant tumours with AR amplification is shown. The cases shown with unbroken lines are those cases that developed AR amplification in the transition from hormone-sensitive to hormone-resistant disease. All cases had an increase in AR protein expression with the development of AR amplification, However, only eight out of the nine cases significantly increased. The case shown with the broken line had AR gene amplification in the hormone-sensitive and hormone-resistant tumour. This case had a significant decrease in AR protein expression with the development of hormone resistance. (B) The AR protein mean histoscore for 41 matched hormone-sensitive and hormone-resistant tumours with out AR amplification are shown. In 14 out of 41 (35%) cases, AR expression increased markedly with the development of hormone relapse.
See this image and copyright information in PMC

References

    1. Armitage P, Berry G (1995) Statistical Methods in Medical Research, 3 rd ed. Oxford: Blackwell Science
    1. Avila DM, Zoppi S, McPhaul (2001) The androgen receptor in syndromes of insensitivity and prostate cancer. J Steroid Biochem Mol Biol 76: 135–142 - PubMed
    1. Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch, MJ, Sauter G, Kallioniemi O-P (1999) Survey of gene amplifications during prostate cancer progression by high throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res 59: 803–806 - PubMed
    1. Culig Z, Hobisch A, Hittmair A, Peterziel H, Cato AC, Bartsch G, Klocker H (1998) Expression, structure, and function of androgen receptor in advanced prostatic carcinoma. Prostate 35: 63–70 - PubMed
    1. Edwards J, Krishna NS, Mukherjee R, Watters AD, Underwood MA, Bartlett JMS (2001) Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer. Br J Urol Int 88: 633–637 - PubMed

MeSH terms

Substances